TrianglePUBLICATIONS · 35030036
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Apr 10
- First author
- Giné E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Giné E
- type
- Author
- name
- de la Cruz F
- type
- Author
- name
- Jiménez Ubieto A
- type
- Author
- name
- López Jimenez J
- type
- Author
- name
- Martín García-Sancho A
- type
- Author
- name
- Terol MJ
- type
- Author
- name
- González Barca E
- type
- Author
- name
- Casanova M
- type
- Author
- name
- de la Fuente A
- type
- Author
- name
- Marín-Niebla A
- type
- Author
- name
- Muntañola A
- type
- Author
- name
- González-López TJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Giné E
- type
- Author
- name
- de la Cruz F
- type
- Author
- name
- Jiménez Ubieto A
- type
- Author
- name
- López Jimenez J
- type
- Author
- name
- Martín García-Sancho A
- type
- Author
- name
- Terol MJ
- type
- Author
- name
- González Barca E
- type
- Author
- name
- Casanova M
- type
- Author
- name
- de la Fuente A
- type
- Author
- name
- Marín-Niebla A
- type
- Author
- name
- Muntañola A
- type
- Author
- name
- González-López TJ
- type
- Author
- bibliography ids
- nci-bib-50f00dbe7da97dff0bf1b352
- book metadata
- content sha256
- 5863b86eb00dabd5463264b7885e2c6ee614a3d73827e754f27a50316b0e7d9a
- document type
- citation
- dois
- 10.1200/JCO.21.02321
- electronic publication date
- display
- 2022 Jan 14
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35030036
- immutable id
- pubmed:35030036@5863b86eb00dabd5463264b7885e2c6ee614a3d73827e754f27a50316b0e7d9a
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 11
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1196-1205
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35030036
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- e97c24872d1861677d3a402958130272b3445e7099e752e6a6c33c21c8fa2219
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Apr 10
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Preserved source evidence · Not medical advice